160 related articles for article (PubMed ID: 2828746)
1. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.
Ura N; Carretero OA; Erdös EG
Kidney Int; 1987 Oct; 32(4):507-13. PubMed ID: 2828746
[TBL] [Abstract][Full Text] [Related]
2. Contributions of various rat plasma peptidases to kinin hydrolysis.
Ishida H; Scicli AG; Carretero OA
J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
[TBL] [Abstract][Full Text] [Related]
3. A sensitive method for differential determination of kininase I, II and neutral endopeptidase (NEP) in human urine.
Ogata H; Ura N; Shimamoto K; Sakakibara T; Ando T; Nishimiya T; Nakagawa M; Fukuyama S; Masuda A; Yamaguchi Y
Adv Exp Med Biol; 1989; 247B():343-8. PubMed ID: 2558508
[TBL] [Abstract][Full Text] [Related]
4. Effects of a kinin antagonist on renal function in rats.
Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of placental proteases in bradykinin (BK) degradation.
Kuno N; Mizutani S; Ohno Y; Goto K; Itakura A; Kondo I; Kurauchi O; Kikkawa F; Tomoda Y
Reprod Fertil Dev; 1997; 9(6):633-9. PubMed ID: 9551668
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
8. The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats.
Ura N; Shimamoto K; Kuroda S; Nomura N; Iwata M; Aoyama T; Iimura O
Clin Exp Hypertens; 1994 Nov; 16(6):799-808. PubMed ID: 7858560
[TBL] [Abstract][Full Text] [Related]
9. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
McCaa RE
Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
[TBL] [Abstract][Full Text] [Related]
10. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
Salgado HC; Carretero OA; Scicli AG; Murray RD
J Pharmacol Exp Ther; 1986 Apr; 237(1):204-8. PubMed ID: 2420968
[TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins.
Ishida H; Scicli AG; Carretero OA
Hypertension; 1989 Sep; 14(3):322-7. PubMed ID: 2548961
[TBL] [Abstract][Full Text] [Related]
12. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea.
Dusser DJ; Nadel JA; Sekizawa K; Graf PD; Borson DB
J Pharmacol Exp Ther; 1988 Feb; 244(2):531-6. PubMed ID: 3279179
[TBL] [Abstract][Full Text] [Related]
13. Renal kininases in primary aldosteronism.
Ura N; Shimamoto K; Ogata H; Sakakibara T; Ando T; Fukuyama S; Nakagawa M; Saito S; Tanaka S; Iimura O
Adv Exp Med Biol; 1989; 247B():145-50. PubMed ID: 2558506
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin degrading activity in cultured human endothelial cells.
Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
16. The natriuretic mechanisms of neutral endopeptidase inhibitor in rats.
Shimamoto K; Ura N; Iimura O
Braz J Med Biol Res; 1994 Aug; 27(8):1965-73. PubMed ID: 7749388
[TBL] [Abstract][Full Text] [Related]
17. Influence of kinins and angiotensin II on the regulation of papillary blood flow.
Roman RJ; Kaldunski ML; Scicli AG; Carretero OA
Am J Physiol; 1988 Oct; 255(4 Pt 2):F690-8. PubMed ID: 2845811
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
Ward PE; Chow A; Drapeau G
Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
[TBL] [Abstract][Full Text] [Related]
19. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
Nasjletti A; Colina-Chourio J; McGiff JC
Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
[TBL] [Abstract][Full Text] [Related]
20. Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.
Legault L; Cernacek P; Levy M; Maher E; Farber D
J Clin Invest; 1992 Oct; 90(4):1425-35. PubMed ID: 1328299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
